These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12067484)

  • 1. Apolipoprotein E: a major piece in the Alzheimer's disease puzzle.
    Cedazo-Mínguez A; Cowburn RF
    J Cell Mol Med; 2001; 5(3):254-66. PubMed ID: 12067484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities.
    Cedazo-Mínguez A
    J Cell Mol Med; 2007; 11(6):1227-38. PubMed ID: 18205697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.
    Butterfield DA; Mattson MP
    Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
    Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
    J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.
    Arold S; Sullivan P; Bilousova T; Teng E; Miller CA; Poon WW; Vinters HV; Cornwell LB; Saing T; Cole GM; Gylys KH
    Acta Neuropathol; 2012 Jan; 123(1):39-52. PubMed ID: 22020632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
    Poirier J
    Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease.
    Lane RM; Farlow MR
    J Lipid Res; 2005 May; 46(5):949-68. PubMed ID: 15716586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
    Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
    Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease.
    Dorey E; Chang N; Liu QY; Yang Z; Zhang W
    Neurosci Bull; 2014 Apr; 30(2):317-30. PubMed ID: 24652457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
    Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
    J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
    Aleshkov S; Abraham CR; Zannis VI
    Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of amyloid-beta with ApoE.
    Carter DB
    Subcell Biochem; 2005; 38():255-72. PubMed ID: 15709483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?
    Kanekiyo T; Xu H; Bu G
    Neuron; 2014 Feb; 81(4):740-54. PubMed ID: 24559670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Roles of Apolipoprotein E4 in Oxidative Lipid Metabolism and Ferroptosis During the Pathogenesis of Alzheimer's Disease.
    Faraji P; Kühn H; Ahmadian S
    J Mol Neurosci; 2024 Jul; 74(3):62. PubMed ID: 38958788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.
    Zhao N; Liu CC; Qiao W; Bu G
    Biol Psychiatry; 2018 Feb; 83(4):347-357. PubMed ID: 28434655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples.
    Tai LM; Bilousova T; Jungbauer L; Roeske SK; Youmans KL; Yu C; Poon WW; Cornwell LB; Miller CA; Vinters HV; Van Eldik LJ; Fardo DW; Estus S; Bu G; Gylys KH; Ladu MJ
    J Biol Chem; 2013 Feb; 288(8):5914-26. PubMed ID: 23293020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of ApoE4 on the Pathogenesis in Alzheimer's Disease and the Potential Therapeutic Approaches.
    Sun YY; Wang Z; Huang HC
    Cell Mol Neurobiol; 2023 Oct; 43(7):3115-3136. PubMed ID: 37227619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease.
    Bales KR
    Neuropharmacology; 2010; 59(4-5):295-302. PubMed ID: 20079752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease.
    Ayyubova G
    CNS Neurol Disord Drug Targets; 2024; 23(3):342-352. PubMed ID: 36872358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.